July 13, 2021

TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder

June 22, 2021

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody Candidate AUG-3387 for Clinical Development Against COVID-19

June 7, 2021

TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing Applications

May 25, 2021

TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

May 13, 2021

TFF Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

May 4, 2021

TFF Pharmaceuticals to Hold First Quarter 2021 Financial and Business Results Conference Call on May 13, 2021

April 13, 2021

TFF Pharmaceuticals Awarded Contract under DARPA’s Next-Generation Personalized Protective Biosystems Program for U.S. Warfighters

March 26, 2021

TFF Pharmaceuticals Prices Offering of Common Stock

March 10, 2021

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results

March 9, 2021

NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration